01416nam 2200397Ia 450 991069694420332120230902161730.0(CKB)5470000002383451(OCoLC)551744655(EXLCZ)99547000000238345120100312d2003 ua 0enguran|||||||||txtrdacontentcrdamediacrrdacarrierGuidance for indusry[electronic resource] bioavailability and bioequivalence studies for nasal aerosols and nasal sprays for local actionRockville, MD :U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research,[2003]1 electronic resource (36 pages)'Biopharmaceutics.""April 2003."Includes bibliographical references (page 34).Guidance for indusry AerosolsBioavailabilityAerosol therapyUnited StatesDrugsUnited StatesTherapeutic equivalencyAerosolsBioavailability.Aerosol therapyDrugsTherapeutic equivalency.Center for Drug Evaluation and Research (U.S.)GPOGPOBOOK9910696944203321Guidance for indusry3467946UNINA